Provider organizations are using generative AI for all sorts of use cases. It’s delivering impressive returns in two—tech support and patient experience.
No medications are currently approved for the treatment of nonobstructive hypertrophic cardiomyopathy. Could a new drug from Imbria Pharmaceuticals be the first?
Last month, the Department of Commerce launched an investigation into the importing of such items, seeking to determine the impact on national security.
Authorities granted 510(k) clearance for Brain Health in late September, with the Los Angeles-based imaging center operator touting the decision Tuesday.
ACR’s board has chosen Hedvig Hricak, MD, PhD, and Debra Monticciolo, MD, as its next honorees, who will be recognized at the organization’s 2026 annual meeting in May.
It is estimated that less than 20% of eligible patients in the U.S. adhere to LCS recommendations, despite numerous studies highlighting the exam’s effectiveness.
Field Medical's FieldForce Ablation System. Image courtesy of Field Medical.
More research is still required, but Field Medical's FieldForce Ablation System may represent a significant step forward in the treatment of scar-related ventricular tachycardia.
